Can ibrutinib ameliorate outcomes in R/R ABC-DLBCL undergoing autoSCT? Presented ByDr Charalambos Andreadis, University of California San Francisco, USA TrialPhase 3, A051301/BMT-CTN 1201 ConferenceASH 2023 7 February, 2024 14:59